Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1026-1032

  Kruse, Lori ^a   Mitchell, Alice M ^a   Camargo Jr , Carlos A ^b   Hernandez, Jackeline ^a   Kline, Jeffrey A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; HOMOCYSTEINE; PROTHROMBIN;

ADULT; AMBULATORY CARE; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPNEA; EMERGENCY WARD; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THORAX PAIN; THROMBOPHILIA; THROMBOSIS; URBAN AREA;

ACUTE DISEASE; CASE-CONTROL STUDIES; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FACTOR V; FEMALE; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; PROTHROMBIN; PULMONARY EMBOLISM; SYNDROME; THROMBOPHILIA; VARIATION (GENETICS);

EID: 33646920601     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.061861     Document Type: Article

References (37)

1. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162:1245-8.
2. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19-25.
3. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:14-8.
4. Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 2003;1:80-7.
5. Portale G, Mazzone M, Travaglino F, Buccelletti F, Gentiloni-Silveri N. 'Idiopathic' pulmonary embolism. Am J Emerg Med 2003;21:245-6.
6. Andrew TA, Fairweather R. Prothrombin G20210A mutation and sudden death. Am J Forensic Med Pathol 2003;24:377-80.
7. Miller EJ, Marques MB, Simmons GT. Etiology of pulmonary thromboembolism in the absence of commonly recognized risk factors. Am J Forensic Med Pathol 2003;24:329-33.
8. Ely SF, Gill JR. Fatal pulmonary thromboembolism and hereditary thrombophilias. J Forensic Sci 2005;50:411-8.
9. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 1999;81:733-8.
10. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82:610-9.
11. Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation 2004;109:14-8.
12. Eckman MH, Singh SK, Erban JK, Kao G. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Med Decis Making 2002;22:108-24.
13. Hainaut P, Jaumotte C, Verhelst D, Wallemacq P, Gala JL, Lavenne E, et al. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases. Thromb Res 2002;106:121-5.
14. Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1995;92:2800-2.
15. Chunilal SD, Eikelboom JW, Attia J, Miniati M, Panju AA, Simel DL, et al. Does this patient have pulmonary embolism? JAMA 2003;290:2849-58.
16. Kearon C. Diagnosis of pulmonary embolism. Can Med Assoc J 2003;168:183-94.
17. Kline JA, Wells PS. Methodology for a rapid protocol to rule out pulmonary embolism in the emergency department. Ann Emerg Med 2003;42:266-75.
18. Tsai AW, Cushman M, Tsai MY, Heckbert SR, Rosamond WD, Aleksic N, et al. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol 2003;72:192-200.
19. den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR, and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
20. den Heijer M, Blom HJ, Gerrits WB, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet 1995;345:882-5.
21. Quere I, Perneger TV, Zittoun J, Bellet H, Gris JC, Daures JP, et al. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Lancet 2002;359:747-52.
22. de Moerloose P, Bounameaux HR, Mannucci PM. Screening tests for thrombophilic patients: which tests, for which patient, by whom, when, and why? Semin Thromb Hemost 1998;24:321-7.
23. Kabrhel C, McAfee AT, Goldhaber SZ. The contribution of the subjective component of the Canadian Pulmonary Embolism Score to the overall score in emergency department patients. Acad Emerg Med 2005;12:915-20.
24. Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-20.
25. Miniati M, Prediletto R, Formichi B, Marini C, Di Ricco G, Tonelli L, et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999;159:864-71.
26. Kline JA, Johnson CL, Webb WB, Runyon MS. Prospective study of clinician-entered research data in the emergency department using an internet-based system after the HIPAA Privacy Rule. BMC Med Inform Decis Mak 2004;4:17.
27. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002;162:1182-9.
28. Richman PB, Wood J, Kasper DM, Collins JM, Petri RW, Field AG, et al. Contribution of indirect computed tomography venography to computed tomography angiography of the chest for the diagnosis of thromboembolic disease in two United States emergency departments. J Thromb Haemost 2003;1:652-7.
29. Kline JA, Webb WB, Jones AE, Hernandez J. Impact of a rapid rule-out protocol for pulmonary embolism on the rate of screening, missed cases, and pulmonary vascular imaging in an urban U.S. emergency department. Ann Emerg Med 2004;44:490-503.
30. Kline JA, Mitchell AM, Runyon MS, Jones AE, Webb WB. Electronic medical record review as a surrogate to telephone follow-up to establish outcome for diagnostic research studies in the emergency department. Acad Emerg Med 2005;12:1127-33.
31. Mitchell AM, Garvey JL, Chandra A, Diercks DB, Pollack CV, Kline JA. Prospective study of quantitative pretest probability assessment for acute coronary syndromes in patients evaluated in emergency department chest pain units. Ann Emerg Med 2006;46.
32. Bertina RM, Koeleman BP, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
33. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996;86:726-8.
34. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism-pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled Analysis in Venous Thromboembolism. Thromb Haemost 2001;86:809-16.
35. Juul K, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 2004;140:330-7.
36. Vandenbroucke JP, Rosendaal FR. Factor V Leiden and venous thromboembolism. Ann Intern Med 2004;141:484.
37. Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, et al. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 2002;99:2720-5.